186
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Helicobacter pylori Infection as a Risk Factor for Abnormal Serum Protein Levels in General Population of China

, ORCID Icon, , , , & show all
Pages 2009-2017 | Published online: 26 Mar 2022

References

  • Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–429. doi:10.1053/j.gastro.2017.04.022
  • Subsomwong P, Miftahussurur M, Uchida T, et al. Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand. PLoS One. 2017;12(10):e0187113. doi:10.1371/journal.pone.0187113
  • Wang X, Shu X, Li Q, et al. Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high-risk area for gastric cancer in northwest China: an all-ages population-based cross-sectional study. Helicobacter. 2021;26(4):e12810. doi:10.1111/hel.12810
  • Moss S, Calam J, Agarwal B, Wang S, Holt P. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut. 1996;38(4):498–501. doi:10.1136/gut.38.4.498
  • Cahill RJ, Sant S, Beattie S, Hamilton H, O’Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol. 1994;6(12):1123–1128. doi:10.1097/00042737-199412000-00010
  • Sugimoto M, Furuta T, Yamaoka Y. Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol. 2009;24(11):1725–1732. doi:10.1111/j.1440-1746.2009.06047.x
  • Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67(2):226–236. doi:10.1136/gutjnl-2017-314205
  • Kim TJ, Sinn DH, Min YW, et al. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. J Gastroenterol. 2017;52(11):1201–1210. doi:10.1007/s00535-017-1337-y
  • Dutta SK, Arora M, Kireet A, Bashandy H, Gandsas A. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci. 2009;54(6):1243–1246. doi:10.1007/s10620-008-0485-6
  • Dhurandhar N, Bailey D, Thomas D. Interaction of obesity and infections. Obes Rev. 2015;16(12):1017–1029. doi:10.1111/obr.12320
  • Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol. 2011;17(10):1249–1260. doi:10.3748/wjg.v17.i10.1249
  • Franceschi F, Annalisa T Di Rienzo Teresa D, et al. Role of Helicobacter pylori infection on nutrition and metabolism. World J Gastroenterol. 2014;20(36):12809. doi:10.3748/wjg.v20.i36.12809
  • Li J-Z, Li J-Y, Wu T-F, et al. Helicobacter pylori infection is associated with type 2 diabetes, not type 1 diabetes: an updated meta-analysis. Gastroenterol Res Pract. 2017;2017:1–15. doi:10.1155/2017/5715403
  • Marietti M, Gasbarrini A, Saracco G, Pellicano R. Helicobacter pylori infection and diabetes mellitus: the 2013 state of art. Panminerva Med. 2013;55(3):277–281.
  • Greenough C, Jenkins RE, Kitteringham NR, Pirmohamed M, Park BK, Pennington SRJP. A method for the rapid depletion of albumin and immunoglobulin from human plasma. Proteomics. 2004;4(10):3107-3111.
  • Levey AS, Coresh J, Bolton K, et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl. 1):i–ii+ S1–S266.
  • Jalalzadeh M, Saber HR, Vafaeimanesh J, Mirza MF, Falaknazi K. Association of Helicobacter Pylori Infection and Serum Albumin in Patients on Hemodialysis. Iran J Kidney Dis. 2010;4:312–316.
  • Noto JM, Peek RM, Leong JM. The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog. 2017;13(10):e1006573. doi:10.1371/journal.ppat.1006573
  • Yu Y, Cai J, Song Z, Wang J, Wu L. Association of Helicobacter pylori infection with metabolic syndrome in aged Chinese females. Exp Ther Med. 2019;17(6):4403–4408. doi:10.3892/etm.2019.7509
  • Lim SH, Kim N, Kwon JW, et al. Positive association between Helicobacter pylori infection and metabolic syndrome in a Korean population: a multicenter nationwide study. Dig Dis Sci. 2019;64(8):2219–2230. doi:10.1007/s10620-019-05544-3
  • Shimamoto T, Yamamichi N, Gondo K, et al. The association of Helicobacter pylori infection with serum lipid profiles: an evaluation based on a combination of meta-analysis and a propensity score-based observational approach. PLoS One. 2020;15(6):e0234433. doi:10.1371/journal.pone.0234433
  • O’Connor A, Furuta T, Gisbert JP, O’Morain C. Review–treatment of Helicobacter pylori infection 2020. Helicobacter. 2020;25:e12743. doi:10.1111/hel.12743
  • Furuta T, Shirai N, Xiao F, Takashima M, Hanai H. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther. 2002;16(4):799–806. doi:10.1046/j.1365-2036.2002.01222.x
  • Gyulai Z, Klausz G, Tiszai A, et al. Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. Eur Cytokine Netw. 2004;15(4):353–358.
  • Hofman V, Lassalle S, Selva E, et al. Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis. J Clin Pathol. 2007;60(6):600–607. doi:10.1136/jcp.2006.040741
  • Balat MN, Fahmy Zanaty MA, EL-Antouny NG, Ahmed HK. Association between proteinuria and active Helicobacter pylori infection in non-diabetic patients. Zagazig Univ Med J. 2019;25(1):79–84. doi:10.21608/zumj.2019.23702
  • Bagirova M, Allahverdiyev AM, Abamor ES, Aliyeva H, Unal G, Tanalp TD. An overview of challenges to eradication of Helicobacter pylori infection and future prospects. Eur Rev Med Pharmacol Sci. 2017;21(9):2199–2219.
  • Moyat M, Velin D. Immune responses to Helicobacter pylori infection. World J Gastroenterol. 2014;20(19):5583–5593. doi:10.3748/wjg.v20.i19.5583